Current status and prospects of the treatment of juvenile idiopathic arthritis
10.3760/cma.j.cn101070-20200728-01260
- VernacularTitle:幼年特发性关节炎治疗现状与展望
- Author:
Sirui YANG
1
;
Lishuang GUO
;
Jinxiang LIU
;
Congcong LIU
Author Information
1. 吉林大学第一医院儿童风湿免疫过敏科，长春 130021
- Keywords:
Idiopathic arthritis, juvenile;
Therapy;
Current status;
Prospects
- From:
Chinese Journal of Applied Clinical Pediatrics
2022;37(1):6-12
- CountryChina
- Language:Chinese
-
Abstract:
Juvenile idiopathic arthritis (JIA) is a genetically heterogeneous group of connective tissue diseases that are commonly characterized by chronic joint synovial inflammation with unknown etiology in childhood.It is cu-rrently incurable and the main therapeutic goal is to achieve clinical remission.The drugs currently used to treat JIA mainly include non-steroid anti-inflammatory drugs, glucocorticoid, disease modifying antirheumatic drugs, and biological agents.In this article, recent advances in the understanding of JIA treatment and related clinical research were reviewed, in an attempt to provide prospects for the future direction of drug development and treatment concepts.
